All Posts By

Smartkarma Daily Briefs

Daily Brief South Korea: Samyang Foods, Naver Corp and more

By | Daily Briefs, South Korea

In today’s briefing:

  • KOSPI 200 Ad-Hoc Change: Hyundai Greenfood Out & Samyang Foods Fresh Buy-In on April 10
  • Naver (2023 High Conviction Update): Turbo-Charged by Expected Launch of Korean Version of ChatGPT

KOSPI 200 Ad-Hoc Change: Hyundai Greenfood Out & Samyang Foods Fresh Buy-In on April 10

By Sanghyun Park

  • From a trading perspective, we should pay attention to the KOSPI 200 corporate actions in Hyundai Department Group’s demerger events, as both companies are KOSPI 200 constituents.
  • Hyundai Green Food’s surviving company won’t beat the cutoff, resulting in a KOSPI 200 constituent change on April 10. Samyang Foods will be a new addition.
  • Even the size of KOSPI 200 ETFs that will likely go into mechanical trading on April 10 will cause a significant price impact from a day trading perspective.

Naver (2023 High Conviction Update): Turbo-Charged by Expected Launch of Korean Version of ChatGPT

By Douglas Kim

  • Naver plans to launch its own Korean version of ChatGPT in 1H 2023.
  • We believe that this will act as an important catalyst that is likely to further fuel Naver’s share price higher. 
  • Naver has been our high conviction call in 2023 and we continue to have a Positive view of Naver. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief India: Adani Enterprises, Adani Ports & Special Economic Zone, Syngene International Ltd, Lippo Karawaci, IndiaFirst Life Insurance, Tata Steel Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • MSCI Acts Quickly: Unmitigated Bad News for Adani Group Companies
  • Adani Ports – Earnings Flash – 9M FY 2022-23 Results – Lucror Analytics
  • Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind
  • Morning Views Asia: Adani Green Energy, Lippo Karawaci
  • IndiaFirst Life Insurance Pre-IPO – Hardly Stands Out as One of the Smallest Players
  • Tata Steel – Earnings Flash – Q3 FY 2022-23 Results – Lucror Analytics

MSCI Acts Quickly: Unmitigated Bad News for Adani Group Companies

By Brian Freitas

  • In an unprecedent step, MSCI will reassess the float and likely lower the FIF of the Adani Group companies at the February QCIR. There will be BIG passive selling.
  • The affected securities will be further reviewed as part of the scheduled Full Country Float Review during the May QCIR. There could be some index deletions and BIGGER passive selling.
  • Expect active selling before the passive selling and the rally in the Adani Group stocks over the last couple of days should come to a grinding halt today.

Adani Ports – Earnings Flash – 9M FY 2022-23 Results – Lucror Analytics

By Leonard Law, CFA

Adani Ports and Special Economic Zone’s 9M/22-23 results were broadly stable. The main takeaway was management’s commitment to reduce debt by INR 50 bn using FCF in FY 2023-24, supported by lower capex and limiting new acquisitions. This would cover the INR 16 bn in repayments for onshore bonds maturing in H1/23-24, as well as the prepayment of certain bank debt. Management expects the company to generate the same amount of FCF in FY 2024-25, which would be channelled to repay the USD 650 mn ADSEZ 3.375 24 due in July 2024.


Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind

By Tina Banerjee

  • Syngene International Ltd (SYNG IN) provides integrated services from early discovery to commercial supply across all major therapeutic areas and modalities. The company has 400+ active clients.
  • To capitalize on the secular industry tailwind, the company has been investing to enhance capacity and capability, which has led to extension of existing client relations and engaging new clients.
  • For FY23, the company expects high-teens revenue growth and EBITDA margin of ~30%. Operating leverage is expected to improve from next year onwards, and that should improve the overall profitability.

Morning Views Asia: Adani Green Energy, Lippo Karawaci

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


IndiaFirst Life Insurance Pre-IPO – Hardly Stands Out as One of the Smallest Players

By Ethan Aw

  • IndiaFirst Life Insurance (1083896D IN) is looking to raise about US$250m in its upcoming India IPO. 
  • IndiaFirst Life Insurance (IFLI) is a private life insurer in India with a product portfolio of retail and group products, ranging across different segments. 
  • Its GWP and AUM have grown over the track record period. However, bottomline growth has on the other hand, declined further. 

Tata Steel – Earnings Flash – Q3 FY 2022-23 Results – Lucror Analytics

By Trung Nguyen

Tata Steel has reported significantly weaker than expected Q3/22-23 results. This was driven by a material loss in the European business. Meanwhile, the Indian operations remained reasonable. The consolidated financial risk profile deteriorated significantly, albeit Net Debt/EBITDA remained within the company’s long-term target. Liquidity is adequate.

The next few quarters are likely to be weaker for Tata Steel in Europe, as markets remain subdued. Steel prices are projected to weaken in Q4/22-23, with the drop likely to be steeper than the decline in coking coal and iron ore prices.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Japan: Toshiba Corp, CELSYS, AGC Inc, Ihara Science, Fancl Corp, Sumitomo Electric Industries, FUJIFILM Holdings, Internet Initiative Japan and more

By | Daily Briefs, Japan

In today’s briefing:

  • Toshiba (6502) – Whoop! There It Is!
  • TOPIX Inclusions: Who Is Ready (Feb 2023)
  • AGC (5201 JP) – A Big Buyback
  • Ihara Science (5999 JP) Sees the Chairman Launch an MBO. I Might Expect Excitement.
  • FANCL: The Flagship FANCL Brand in Trouble
  • Ihara Science (5999 JP): JPY2,980 MBO Tender Offer
  • Sumitomo Electric Industries (5802 JP) – LT Momentum Confirms Material Upside Potential in 2023
  • Fujifilm: Robust Quarter; Recent M&A to Drive Healthcare and Materials Biz Further
  • IIJ (Buy) – Q3 22 Results Reaction: Solid Quarter as Recurring Sales Expand

Toshiba (6502) – Whoop! There It Is!

By Travis Lundy

  • As mentioned yesterday here and more clearly by Mio Kato in Toshiba – Good News?, the Nikkei was strangely silent over the fact that loan details were agreed. 
  • The Nikkei comes out with a surprise article this morning saying they hear the Commitment Letter has been handed over. It also says the “Final Bid” is “about ¥2trln.”
  • Toshiba shares quickly reacted badly quickly. The article deserves parsing and I try to clarify the arguments.

TOPIX Inclusions: Who Is Ready (Feb 2023)

By Janaghan Jeyakumar, CFA

  • Quiddity’s “Who is Ready” series of insights aims to objectively identify names listed on the Tokyo Stock Exchange that are potential additions to the TOPIX Index in future.
  • This insight is a follow-up to TOPIX Inclusions: Who Is Ready (Jan 2023) 
  • Our top pick from the last insight CELSYS (3663 JP) (previously known as Artspark) has gained ~14% in roughly a month.

AGC (5201 JP) – A Big Buyback

By Travis Lundy

  • AGC Inc (5201 JP) today announced Q4 earnings where revenues were great, OP was slightly disappointing, and Net Profits were awful because of significant impairments.
  • The company, however, announced a large buyback – its first in 5 years and equivalent to all the buybacks in the previous five years. 
  • The buyback should have impact on what is an interesting name with broad institutional ownership and not overwhelming liquidity.

Ihara Science (5999 JP) Sees the Chairman Launch an MBO. I Might Expect Excitement.

By Travis Lundy

  • Ihara Science (5999 JP) announced an MBO by the chairman. 
  • It’s at an all-time high, but it is not especially attractive. The register is also really interesting.
  • This is a smallcap but i would not be surprised to see a bumpitrage effort. In fact, I’d be surprised if we didn’t.

FANCL: The Flagship FANCL Brand in Trouble

By Oshadhi Kumarasiri

  • Fancl Corp (4921 JP) delivered 3QFY23 results yesterday, which saw revenue and operating profit decrease by 2.5% and 5.0% YoY respectively to ¥28.3bn (consensus ¥29.8bn) and ¥3.1bn (consensus ¥3.4bn).
  • Cosmetics growth being the main reason for Fancl’s FY+2 EV/OP of 22.4x, recent trends look scary with cosmetics revenue and OP down 24% and 27% respectively from the pre-COVID level.
  • Therefore, we would look to short Fancl expecting shares to fall around 25-30% in the short term.

Ihara Science (5999 JP): JPY2,980 MBO Tender Offer

By Arun George

  • Ihara Science (5999 JP) has recommended an MBO tender offer (Chairman and Toku Corporation) of JPY2,980 per share, a 31.3% premium to the undisturbed price (7 February).
  • The transaction is a two-step acquisition through a cash tender offer and subsequent squeeze-out. The lower limit of the tender offer is set at a 66.25% ownership ratio.
  • While the tender price represents an all-time share price, it is light in comparison to peer and historical multiples. This suggests deal risk. The offer runs from 9 Feb-24 Mar.

Sumitomo Electric Industries (5802 JP) – LT Momentum Confirms Material Upside Potential in 2023

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. •1) Response to key levels. •2) Price action. •3) Momentum confirmation.
  • Q1 2023 is confirming that the base built around the historically significant 50 quarter MA since Q3 2021 is likely to be a material LT bottom.
  • Both price action and LT momentum triggers (particularly the quarterly RSI) are confirming a sustainable LT uptrend in 2023 and potentially well into 2024. Potential 20% upswing.

Fujifilm: Robust Quarter; Recent M&A to Drive Healthcare and Materials Biz Further

By Shifara Samsudeen, ACMA, CGMA

  • FUJIFILM Holdings (4901 JP) delivered 3QFY03/2023 results today. Revenue and OP increased 13.5% and 4.1% YoY respectively to JPY744.4bn (consensus JPY717.1bn) and JPY81.8bn (consensus JPY80.0bn).
  • Covid-19 related projects running its course had a slight impact on  healthcare segment but we would not be too worried as new product launches and markets will offset that decline.
  • Market continues to value Fujifilm as an image company and not a healthcare stock and there is more than 30% upside to the current share price.

IIJ (Buy) – Q3 22 Results Reaction: Solid Quarter as Recurring Sales Expand

By Kirk Boodry

  • IIJ delivered double-digit revenue growth for a third consecutive quarter as corporate demand for digitization remains robust
  • In addition the expected expansion of cloud (+15%) and security service (+21%) sales, mobile sales grew 9% as IIJ moved clearly past the impact of industrywide rate reductions
  • Quarterly EBITDA reached a record high even with modest margin contraction YoY

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: China Unicom Hong Kong, Kuaishou Technology, UBTech Robotics, CStone Pharmaceuticals and more

By | China, Daily Briefs

In today’s briefing:

  • China Telcos: Send In The Clouds
  • Kuaishou(1024.HK)4Q22 Preview: Competition and Restructure Are Pending Issues
  • UBTech Robotics IPO Preview
  • CStone Pharmaceuticals Placement (2616.HK) – There Is No Certainty that the Dilemma Will Reverse

China Telcos: Send In The Clouds

By David Blennerhassett

  • The rapid adoption of cloud computing has led to China boasting the world’s second-largest cloud computing market.
  • This migration to the cloud is in lock-step with global customer needs: scale, greater efficiency, and availability; together with a reduction in capex and infrastructure complexity.
  • The big three PRC telcos are firmly in the mix, with each announcing 100%+ growth in revenue for their cloud businesses in 1H22. Expect that trend to continue.

Kuaishou(1024.HK)4Q22 Preview: Competition and Restructure Are Pending Issues

By Shawn Yang

  • We expect that Kuaishou’s 4Q22 top line and bottom line would be 0.2%/3.7% vs cons, as major business lines are recovering with stimuli of CNY promotion campaigns. 
  • However, we estimate that its 2023 top line/bottom line would miss cons. by (0.9%)/(14.2%) due to our concerns of increasing competition and internal restructuring.
  • Maintain SELL rating but raise TP to HK$ 56 to reflect on-track recovering trend as the macro improves. 

UBTech Robotics IPO Preview

By Douglas Kim

  • UBTech Robotics is trying to complete its IPO in Hong Kong in the coming weeks. UBTech Robotics is a leading artificial intelligence based robotics company headquartered in China.
  • UBTech Robotics received very fat valuations in the past couple of years. Back in January 2021, it was reported that the company’s valuation reached as high as $7 billion.
  • In China’s smart education robot based solution market, UBTech Robotics is the number one player. 

CStone Pharmaceuticals Placement (2616.HK) – There Is No Certainty that the Dilemma Will Reverse

By Xinyao (Criss) Wang

  • The revenue brought by CStone’s differentiated layout of pipeline does not match the R&D investment. CStone needs to in-license more late-stage products, but the Company is not cash rich.
  • CStone was incubated by WuXi Bio. Its business model is“VC+IP+CRO”. Cstone doesn’t have independent R&D capability. The increasingly low cost performance of in-licensed products has made the capital “reconsider” .
  • Cstone doesn’t have the potential to be a biopharma as it licensed out the key/core candidates. Its future valuation growth would be “discounted”. Corporate governance/instability is also a concern.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Quantitative Analysis: Growth ETFs: Performance & Factor Exposures and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • Growth ETFs: Performance & Factor Exposures

Growth ETFs: Performance & Factor Exposures

By Nicolas Rabener

  • Growth ETFs are not very differentiated, despite growth having various interpretations
  • 34 out of 40 growth ETFs underperformed the stock market over the last 3 years
  • And neither performance nor factor exposures are desirable. Also, long-term performance attractive not attractive.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Credit: Adani Ports – Earnings Flash – 9M FY 2022-23 Results – Lucror Analytics and more

By | Credit, Daily Briefs

In today’s briefing:

  • Adani Ports – Earnings Flash – 9M FY 2022-23 Results – Lucror Analytics
  • Morning Views Asia: Adani Green Energy, Lippo Karawaci
  • Tata Steel – Earnings Flash – Q3 FY 2022-23 Results – Lucror Analytics

Adani Ports – Earnings Flash – 9M FY 2022-23 Results – Lucror Analytics

By Leonard Law, CFA

Adani Ports and Special Economic Zone’s 9M/22-23 results were broadly stable. The main takeaway was management’s commitment to reduce debt by INR 50 bn using FCF in FY 2023-24, supported by lower capex and limiting new acquisitions. This would cover the INR 16 bn in repayments for onshore bonds maturing in H1/23-24, as well as the prepayment of certain bank debt. Management expects the company to generate the same amount of FCF in FY 2024-25, which would be channelled to repay the USD 650 mn ADSEZ 3.375 24 due in July 2024.


Morning Views Asia: Adani Green Energy, Lippo Karawaci

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Tata Steel – Earnings Flash – Q3 FY 2022-23 Results – Lucror Analytics

By Trung Nguyen

Tata Steel has reported significantly weaker than expected Q3/22-23 results. This was driven by a material loss in the European business. Meanwhile, the Indian operations remained reasonable. The consolidated financial risk profile deteriorated significantly, albeit Net Debt/EBITDA remained within the company’s long-term target. Liquidity is adequate.

The next few quarters are likely to be weaker for Tata Steel in Europe, as markets remain subdued. Steel prices are projected to weaken in Q4/22-23, with the drop likely to be steeper than the decline in coking coal and iron ore prices.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: UBTech Robotics IPO Preview and more

By | Daily Briefs, ECM

In today’s briefing:

  • UBTech Robotics IPO Preview
  • New Ruipeng Pet Group Pre-IPO Peer Comparison – Largest Domestic Player, but Smallest Margins
  • IndiaFirst Life Insurance Pre-IPO – Hardly Stands Out as One of the Smallest Players
  • CStone Pharmaceuticals Placement (2616.HK) – There Is No Certainty that the Dilemma Will Reverse

UBTech Robotics IPO Preview

By Douglas Kim

  • UBTech Robotics is trying to complete its IPO in Hong Kong in the coming weeks. UBTech Robotics is a leading artificial intelligence based robotics company headquartered in China.
  • UBTech Robotics received very fat valuations in the past couple of years. Back in January 2021, it was reported that the company’s valuation reached as high as $7 billion.
  • In China’s smart education robot based solution market, UBTech Robotics is the number one player. 

New Ruipeng Pet Group Pre-IPO Peer Comparison – Largest Domestic Player, but Smallest Margins

By Clarence Chu

  • New Ruipeng Pet Group (RPET US) is looking to raise at least US$100m in its upcoming US IPO.
  • New Ruipeng Pet Group (Ruipeng) is a pet services platform, primarily offering pet care services, supply chain services and local services, covering the entire lifecycle of pets. 
  • In our previous notes, we have looked at the company’s past performance. In this note, we undertake a peer comparison.

IndiaFirst Life Insurance Pre-IPO – Hardly Stands Out as One of the Smallest Players

By Ethan Aw

  • IndiaFirst Life Insurance (1083896D IN) is looking to raise about US$250m in its upcoming India IPO. 
  • IndiaFirst Life Insurance (IFLI) is a private life insurer in India with a product portfolio of retail and group products, ranging across different segments. 
  • Its GWP and AUM have grown over the track record period. However, bottomline growth has on the other hand, declined further. 

CStone Pharmaceuticals Placement (2616.HK) – There Is No Certainty that the Dilemma Will Reverse

By Xinyao (Criss) Wang

  • The revenue brought by CStone’s differentiated layout of pipeline does not match the R&D investment. CStone needs to in-license more late-stage products, but the Company is not cash rich.
  • CStone was incubated by WuXi Bio. Its business model is“VC+IP+CRO”. Cstone doesn’t have independent R&D capability. The increasingly low cost performance of in-licensed products has made the capital “reconsider” .
  • Cstone doesn’t have the potential to be a biopharma as it licensed out the key/core candidates. Its future valuation growth would be “discounted”. Corporate governance/instability is also a concern.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Technical Analysis: Sumitomo Electric Industries (5802 JP) – LT Momentum Confirms Material Upside Potential in 2023 and more

By | Daily Briefs, Technical Analysis

In today’s briefing:

  • Sumitomo Electric Industries (5802 JP) – LT Momentum Confirms Material Upside Potential in 2023

Sumitomo Electric Industries (5802 JP) – LT Momentum Confirms Material Upside Potential in 2023

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. •1) Response to key levels. •2) Price action. •3) Momentum confirmation.
  • Q1 2023 is confirming that the base built around the historically significant 50 quarter MA since Q3 2021 is likely to be a material LT bottom.
  • Both price action and LT momentum triggers (particularly the quarterly RSI) are confirming a sustainable LT uptrend in 2023 and potentially well into 2024. Potential 20% upswing.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Thematic (Sector/Industry): Good Morning Japan |Hawks Re-Emerge + Epic “BARD” Fail Sinks Google; Pan Pac Beat/Subaru Miss and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Good Morning Japan |Hawks Re-Emerge + Epic “BARD” Fail Sinks Google; Pan Pac Beat/Subaru Miss

Good Morning Japan |Hawks Re-Emerge + Epic “BARD” Fail Sinks Google; Pan Pac Beat/Subaru Miss

By Mark Chadwick

  • OVERSEAS. SPX -1.1% as Fed Hawks rhetoric ratches up; All 11 Sectors -ve as Beta Sold; ALPHABET-7.7% AI fails to impress; Disney +8% after-hours with earnings beat/job cuts.
  • JAPAN.  NKY Futs -0.8% vs Cash; USDJPY 131.41; Japan looking to ease restrictions for China Inbound;  EARNINGS: Pan Pac/SMM Strong vs weak Subaru which -ve production cut; Toyota out today.
  • DAILY NUGGETS. EPIC fail from Alphabet’s “BARD”. Aren’t these events supposed to  be choreographed ????

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Equity Bottom-Up: China Telcos: Send In The Clouds and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • China Telcos: Send In The Clouds
  • Kuaishou(1024.HK)4Q22 Preview: Competition and Restructure Are Pending Issues
  • Naver (2023 High Conviction Update): Turbo-Charged by Expected Launch of Korean Version of ChatGPT
  • FANCL: The Flagship FANCL Brand in Trouble
  • Bank Of Ayudhya (BAY TB) – Thai Retail Wizard Moving to ASEAN
  • Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind
  • Fujifilm: Robust Quarter; Recent M&A to Drive Healthcare and Materials Biz Further
  • IIJ (Buy) – Q3 22 Results Reaction: Solid Quarter as Recurring Sales Expand
  • Lithium Power International – Lithium price upgrade calls for higher valuation
  • ATEN: The Inevitable Push Out

China Telcos: Send In The Clouds

By David Blennerhassett

  • The rapid adoption of cloud computing has led to China boasting the world’s second-largest cloud computing market.
  • This migration to the cloud is in lock-step with global customer needs: scale, greater efficiency, and availability; together with a reduction in capex and infrastructure complexity.
  • The big three PRC telcos are firmly in the mix, with each announcing 100%+ growth in revenue for their cloud businesses in 1H22. Expect that trend to continue.

Kuaishou(1024.HK)4Q22 Preview: Competition and Restructure Are Pending Issues

By Shawn Yang

  • We expect that Kuaishou’s 4Q22 top line and bottom line would be 0.2%/3.7% vs cons, as major business lines are recovering with stimuli of CNY promotion campaigns. 
  • However, we estimate that its 2023 top line/bottom line would miss cons. by (0.9%)/(14.2%) due to our concerns of increasing competition and internal restructuring.
  • Maintain SELL rating but raise TP to HK$ 56 to reflect on-track recovering trend as the macro improves. 

Naver (2023 High Conviction Update): Turbo-Charged by Expected Launch of Korean Version of ChatGPT

By Douglas Kim

  • Naver plans to launch its own Korean version of ChatGPT in 1H 2023.
  • We believe that this will act as an important catalyst that is likely to further fuel Naver’s share price higher. 
  • Naver has been our high conviction call in 2023 and we continue to have a Positive view of Naver. 

FANCL: The Flagship FANCL Brand in Trouble

By Oshadhi Kumarasiri

  • Fancl Corp (4921 JP) delivered 3QFY23 results yesterday, which saw revenue and operating profit decrease by 2.5% and 5.0% YoY respectively to ¥28.3bn (consensus ¥29.8bn) and ¥3.1bn (consensus ¥3.4bn).
  • Cosmetics growth being the main reason for Fancl’s FY+2 EV/OP of 22.4x, recent trends look scary with cosmetics revenue and OP down 24% and 27% respectively from the pre-COVID level.
  • Therefore, we would look to short Fancl expecting shares to fall around 25-30% in the short term.

Bank Of Ayudhya (BAY TB) – Thai Retail Wizard Moving to ASEAN

By Angus Mackintosh

  • Bank Of Ayudhya (BAY TB), now branded as Krungsri, is a unique Thai bank with high-quality retail exposure, a low-risk corporate loan book, and a growing SME book. 
  • The bank is growing its digital exposure through its KMB app, its GO app for auto customers plus its UChoose lifestyle app and it collaborates with Grab and Shopee.
  • Krungsri’s move to acquire Nomura Thailand’s broking business and its acquisition of Home Credit in Indonesia and the Philippines provide an additional edge and ASEAN exposure. Valuations are inexpensive.

Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind

By Tina Banerjee

  • Syngene International Ltd (SYNG IN) provides integrated services from early discovery to commercial supply across all major therapeutic areas and modalities. The company has 400+ active clients.
  • To capitalize on the secular industry tailwind, the company has been investing to enhance capacity and capability, which has led to extension of existing client relations and engaging new clients.
  • For FY23, the company expects high-teens revenue growth and EBITDA margin of ~30%. Operating leverage is expected to improve from next year onwards, and that should improve the overall profitability.

Fujifilm: Robust Quarter; Recent M&A to Drive Healthcare and Materials Biz Further

By Shifara Samsudeen, ACMA, CGMA

  • FUJIFILM Holdings (4901 JP) delivered 3QFY03/2023 results today. Revenue and OP increased 13.5% and 4.1% YoY respectively to JPY744.4bn (consensus JPY717.1bn) and JPY81.8bn (consensus JPY80.0bn).
  • Covid-19 related projects running its course had a slight impact on  healthcare segment but we would not be too worried as new product launches and markets will offset that decline.
  • Market continues to value Fujifilm as an image company and not a healthcare stock and there is more than 30% upside to the current share price.

IIJ (Buy) – Q3 22 Results Reaction: Solid Quarter as Recurring Sales Expand

By Kirk Boodry

  • IIJ delivered double-digit revenue growth for a third consecutive quarter as corporate demand for digitization remains robust
  • In addition the expected expansion of cloud (+15%) and security service (+21%) sales, mobile sales grew 9% as IIJ moved clearly past the impact of industrywide rate reductions
  • Quarterly EBITDA reached a record high even with modest margin contraction YoY

Lithium Power International – Lithium price upgrade calls for higher valuation

By Edison Investment Research

We have raised our near-term lithium price expectations to reflect the current supply/demand cycle and upgraded our long-run (post 2031) price forecasts (from US$17,000/t to US$22,500/t LCE) to reflect lithium’s high demand growth and highly concentrated supply fundamentals. On the back of this, our valuation of Lithium Power International (LPI) has increased from A$1.24/share to A$1.42/share assuming the full project equity dilution. We have also updated our model to reflect 100% consolidation of the Maricunga project as well as LPI’s (now somewhat more dilutive) lower share price.


ATEN: The Inevitable Push Out

By Hamed Khorsand

  • ATEN reported better than expected fourth quarter results, but it was the lack of quantitative revenue guidance that garnering all the attention
  • We had highlighted increased macro risks in our January update leading to 2023 becoming dependent on the second half of the year.
  • The first quarter is seasonally the slowest period of the year for ATEN, which could be the reason for management taking a conservative approach with 2023 guidance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars